Leaps by Bayer
Signal active
Investment Firm
Overview
Leaps by Bayer invests in paradigm-shifting advances in the life sciences and specializes in the fields of biotechnology, agriculture, and scientific breakthrough. The firm's approach is making significant and sustained investments in disruptive biotechnologies that could have the greatest impact on humanity.
It was founded in 2015 and headquartered in Leverkusen, Nordrhein-Westfalen.
Highlights
Founded
2015
Industry
Biotechnology
Employees
11-50
Investment
98
Lead Investment
43
Exits
10
Stages
Early Stage Venture, Seed, Late Stage Venture
Investor Type
Corporate Venture Capital
Location
Europe
Contact Information
Social
Profile Resume
Leaps by Bayer, established in 2015 and headquartered in Europe., specializes in Early Stage Venture, Seed, Late Stage Venture investments across Biotechnology, Service Industry, Agriculture, Financial Services, Venture Capital, Advice, Finance, Impact Investing, Education, Charity. The organization boasts a portfolio of 96 investments, with an average round size of $59.5M and 10 successful exits. Their recent investments include AgBiome, Polaris Partners, ARCH Venture Partners, Bill & Melinda Gates Foundation, Syngenta Ventures. The highest investment round they participated in was $622.3B. Among their most notable exits are AgBiome and Polaris Partners. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Employees
N/A
Investment portfolio
Leaps by Bayer has made 98 investments. Their most recent investment was on Jul 16, 2024, when Huma raised $80.0M.
Leaps by Bayer has made 23 diversity investments. Their most recent diversity investment was on Apr 23, 2024, when Summer Health raised $11.7M.
investments
98
Diversity investments
23
Lead investments
43
Number of exits
10
Investments
98
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Apr 23, 2024 | Summer Health | Health Care | 11.7M |
| May 02, 2024 | Transcarent | Software | 126.0M |
| Jul 16, 2024 | Huma | Information Technology | 80.0M |
| Jul 19, 2024 | - | - | 60.3M |
Exits
10
Funding Timeline
Funding rounds
98
Investors
1
Funds
0
Funding Rounds
98
Leaps by Bayer has raised 98 rounds. Their latest funding was raised on Jul 19, 2024 from a Series B - GRO Biosciences round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Apr 23, 2024 | Series A - Summer Health | - | 11.7M | - |
| May 02, 2024 | Series D - Transcarent | - | 126.0M | - |
| Jul 16, 2024 | Series D - Huma | - | 80.0M | - |
| Jul 19, 2024 | Series B - GRO Biosciences | - | 60.3M | - |
Investors
1
| Investor Name | Lead Investor | Funding Round | Money Raised |
|---|---|---|---|
| - | No | Venture Round - Leaps by Bayer | 0 |
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.